¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ-´ëÇÑÀü¸³¼±ÇÐȸ-ºñ´¢±â°è±âÃÊÀÇÇבּ¸È¸°øµ¿½ÉÆ÷Áö¾ö : 2019-01-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
»ï¼º¼­¿ïº´¿ø ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ-´ëÇÑÀü¸³¼±ÇÐȸ-ºñ´¢±â°è±âÃÊÀÇÇבּ¸È¸°øµ¿½ÉÆ÷Áö¾ö : 2019-01-19
±³À°ÀÏÀÚ : 2019-01-19
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 ´ë°­´ç  
±³À°ÁÖÁ¦ : ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ-´ëÇÑÀü¸³¼±ÇÐȸ-ºñ´¢±â°è±âÃÊÀÇÇבּ¸È¸°øµ¿½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ
´ã´çÀÚ : ±èÀºÁÖ
¿¬¶ôó : 02-704-8574  
À̸ÞÀÏ : app@app2010.com      
±³À°Á¾·ù : ºñ´¢±â°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í »çÀüµî·Ï 2¸¸¿ø, ÇöÀåµî·Ï 3¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 01-19  08:30~08:50 Registration  () 
±âŸ 01-19  08:50~09:00 Opening remark , Ãà»ç  () 
±³À°½Ã°£ 01-19  09:00~09:20 Critical roles of hMAGEA2 in prostate cancer and development of cancer animal model  ¹Ú¼Û(DGIST) 
±³À°½Ã°£ 01-19  09:20~09:40 Identification of novel biomarkers for diagnosis of metastatic prostate cancer  ÀÌ»ó±Ô(°æºÏ´ë ¾à´ë) 
±³À°½Ã°£ 01-19  09:40~10:00 Expression of AR-V7 in urine derived exosomal RNA and development of CRPC  ±¸ÀÚÀ±(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 01-19  10:00~10:20 Feasibility of ctDNA analysis in prostate cancer  Á¶¿µ³²(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 01-19  10:20~10:40 ctDNA to predict prognosis of prostate cancer  Á¶ÀºÇØ(³ì½ÊÀÚÁö³ð) 
È޽Ġ01-19  10:40~11:00 Coffee break  () 
±³À°½Ã°£ 01-19  11:00~11:20 Medical travel among non-Seoul residents to seek prostate cancer treatment in medical facilities of Seoul  ±èÀçÇå(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 01-19  11:20~11:40 National practice patterns and medical costs for prostate cancer in Korea across a 10 year periods  °­È£¿ø(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 01-19  11:40~12:00 Lifestyle risk prediction model for prostate cancer in a Korean population  ±è¼ºÇÑ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 01-19  12:00~12:20 Surgical simulation in Urology  °í¿µÈÖ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 01-19  12:20~12:40 Digital health and future technology  À̰Ǹí(ÃæºÏ´ëÇб³) 
±âŸ 01-19  12:40~12:40 Closing remark  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »õº´µ¿ °Ç¸³±â³ä ºÎõ¼º¸ðº´¿ø ¾È¼¾ÅÍ ½ÉÆ÷Áö¾ö(ºÎõ½Ã ¾È°úÀÇ»çȸ) : 2019-01-21
´ÙÀ½±Û ´ëÇÑ¿Ü°úÇÐȸ ÃÖ¼Òħ½ÀÀû À¯¹æ»ý°Ë ½ÉÆ÷Áö¾ö : 2019-01-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20839 ´ë±¸ 2024 ´ë±¸±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 0 15:42:02
20838 ¼­¿ï »ï¼º¼­¿ïº´¿ø The 21th SMC STROKE SYMPOSIUM, 2024 : 2024-06-22 0 0 15:40:22
20837 ±¤ÁÖ 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-06-21 0 0 15:38:28
20836 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 2±â(2ÀÏÂ÷) : 2024-06-21 0 0 15:37:09
20835 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ 2024³â Á¦ 1ȸ ³»½Ã°æ Áý´ãȸ : 2024-06-21 0 0 15:35:42
20834 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¾È°ú ±Ý¿äÁý´ãȸ : 2024-06-21 0 0 15:34:16
20833 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 1ÀÏÂ÷ : 2024-06-21 0 0 15:30:44
20832 ¼­¿ï Á¦8Â÷ µµºÀ±¸ÀÇ»çȸ Çмú¼¼¹Ì³ª(½ÉÇ÷°üÁúȯ ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á, ºÒ¸éÁõ, Ä¡¸Å¾à¹°Ä¡·á, Ç×Ç÷ÀüÁ¦) : 2024-06-21 0 0 15:29:30
20831 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (2ÀÏÂ÷) : 2024-06-21 0 1 15:27:20
20830 Á¦ÁÖ ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-06-21 0 0 15:26:03
20829 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 2±â(1ÀÏÂ÷) : 2024-06-20 0 0 15:24:06
20828 ºÎ»ê ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ºÎ»êÁöȸ Áý´ãȸ : 2024-06-20 0 0 15:22:45
20827 ºÎ»ê ´ëÇѾȰúÇÐȸ ºÎ»êÁöȸ Á¦ 510ȸ ÇмúÁý´ãȸ : 2024-06-20 0 0 15:20:28
20826 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (1ÀÏÂ÷) : 2024-06-20 0 0 15:19:18
20825 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÅëÁõÇÐȸ ¼­¿ïÁöȸ Áý´ãȸ : 2024-06-20 0 0 15:17:34
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷